Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant <i>Klebsiella Pneumoniae</i>: Exploring A Colistin Sparing Protocol

Fosfomycin has emerged as a very useful antimicrobial in management of extremely drug resistant (XDR) and pan drug resistant (PDR) <i>Klebsiella pneumoniae</i>. In this study, we assessed in-vitro synergy of colistin sparing combinations of fosfomycin (FOS) with meropenem (MEM), tigecycl...

Full description

Bibliographic Details
Published in:	Antibiotics
Main Authors:	Manawr AL-Quraini, Meher Rizvi, Zaaima AL-Jabri, Hiba Sami, Muna AL-Muzahmi, Zakariya AL-Muharrmi, Neelam Taneja, Ibrahim AL-Busaidi, Rajeev Soman
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Subjects:	in-vitro synergy checkerboard assay time kill assay fosfomycin meropenem <i>Klebsiella pneumoniae</i>
Online Access:	https://www.mdpi.com/2079-6382/11/2/153

Similar Items

Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced <i>Acinetobacter baumannii</i>
by: Munawr AL Quraini, et al.
Published: (2023-05-01)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)

Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of fosfomycin
by: Lorenzo Volpicelli, et al.
Published: (2024-06-01)

Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations
by: A. Oliva, et al.
Published: (2023-06-01)

In Vitro Evaluation of Synergy in Carbapenem-resistant Klebsiella pneumoniae Strains with Antibiotic Combinations of Meropenem, Fosfomycin, Colistin, and Tigecycline
by: Özlem KANDEMİR, et al.
Published: (2021-12-01)

Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing <i>K. pneumoniae</i> Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside
by: Alessandra Oliva, et al.
Published: (2021-06-01)

Comparative Genomic Analysis Reveals the Emergence of ST-231 and ST-395 <i>Klebsiella pneumoniae</i> Strains Associated with the High Transmissibility of <i>bla<sub>KPC</sub></i> Plasmids
by: Muna AL-Muzahmi, et al.
Published: (2023-09-01)

Investigation of in vitro efficacy of quercetin-meropenem combination in carbapenemase-producing Klebsiella pneumoniae isolates
by: Özlem Aydemir, et al.
Published: (2023-09-01)

Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin
by: Samar S. Mabrouk, et al.
Published: (2023-07-01)

A Study on the In Vitro Antibacterial Effects of Colistin or Tigecycline Combined with Three Antimicrobial Agents Against Carbapenem-resistant Acinetobacter Baumannii
by: HUANG Weichen, et al.
Published: (2025-09-01)

Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae
by: Fernando Pasteran, et al.
Published: (2012-02-01)

Mapping Antimicrobial Resistance in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> from Complicated Urinary Tract Infections in Oman: Phenotypic and Genotypic Insights
by: Nawal AL Shizawi, et al.
Published: (2025-04-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
by: Vittoria Mattioni Marchetti, et al.
Published: (2023-07-01)

Glycine restores the sensitivity to antibiotics in multidrug-resistant bacteria
by: Cesira Giordano, et al.
Published: (2024-08-01)

In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
by: Wei Yu, et al.
Published: (2017-06-01)

In Vitro Assessment of the Combination of Antibiotics against Some Integron-Harbouring Enterobacteriaceae from Environmental Sources
by: Folake Temitope Fadare, et al.
Published: (2022-08-01)

Carbapenem treatment options for metallo-beta-lactamase: drug screening and dose optimization of meropenem-based combinations against NDM- or IMP-producing Klebsiella pneumoniae
by: Haoyue Che, et al.
Published: (2025-04-01)

Fosfomycin: Uses and potentialities in veterinary medicine
by: D.S. Pérez, et al.
Published: (2014-03-01)

A Subject Review on Some Analytical Methods for Determination of Fosfomycin Drugs
by: Ali Khalil, et al.
Published: (2022-07-01)

The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan
by: Sung-Pin Tseng, et al.
Published: (2017-10-01)

Metabolomics reveals the mechanism of action of meropenem and amikacin combined in the treatment of Pseudomonas aeruginosa
by: Hai Yang, et al.
Published: (2023-12-01)

Honokiol and Magnolol: Insights into Their Antidermatophytic Effects
by: Adriana Trifan, et al.
Published: (2021-11-01)

In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant <i>Helicobacter pylori</i> Strains
by: Paweł Krzyżek, et al.
Published: (2019-11-01)

Effects of meropenem and amikacin on gut microbiota diversity and structure in a neonatal rat model of necrotizing enterocolitis
by: ZHANG Chenghuan, et al.
Published: (2025-09-01)

Evaluation of Drugs with Therapeutic Potential for Susceptibility of Neisseria Gonorrhoeae Isolates from 8 Provinces in China from 2018
by: Zheng XL, et al.
Published: (2020-12-01)

Removal of Meropenem by using Lemna minor
by: Noora Saad, et al.
Published: (2021-10-01)

Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
by: Mona Ahmed Ammar, et al.
Published: (2018-01-01)

In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates
by: Tuba Müderris, et al.
Published: (2024-06-01)

Biogenic synthesis of CuO-NPs as nanotherapeutics approaches to overcome multidrug-resistant Staphylococcus aureus (MDRSA)
by: Gamal M. El-Sherbiny, et al.
Published: (2022-12-01)

In vitro Synergistic and Bactericidal Effects of Aztreonam in Combination with Ceftazidime/ Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam Against Dual-Carbapenemase-Producing Enterobacterales
by: Fu Y, et al.
Published: (2024-09-01)

Antiproliferative and cytotoxic activities of furocoumarins of Ducrosia anethifolia
by: Javad Mottaghipisheh, et al.
Published: (2018-01-01)

In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex
by: Masahiro Shirata, et al.
Published: (2020-08-01)

Synergistic activity of doped zinc oxide nanoparticles with antibiotics: ciprofloxacin, ampicillin, fluconazole and amphotericin B against pathogenic microorganisms
by: NEHA SHARMA, et al.

Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
by: Alexandro Rodríguez-Rojas, et al.
Published: (2013-04-01)

Successful Treatment of Serious Meningitis Caused by Extremely Carbapenem-Resistant Enterobacter cloacae (MIC≥16mg/L) with i.v. Meropenem and i.v. Amikacin Plus Intraventricular Amikacin
by: He Z, et al.
Published: (2019-12-01)

Evaluation of the appropriateness of meropenem prescribing at a tertiary care hospital: A retrospective study in Oman
by: Dunia Al-Hadithi, et al.
Published: (2020-07-01)

Reintroduction of Legacy Antibiotics in Neonatal Sepsis: The Special Role of Fosfomycin and Colistin
by: Maria Baltogianni, et al.
Published: (2024-04-01)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
by: Ruan Z, et al.
Published: (2020-08-01)